Advertisement
Bad versions of a cancer drug are putting child patients at risk. Why is it still on the market?
ResumeHere & Now's Peter O'Dowd talks with reporter Rosa Furneaux about how an ineffective version of a drug that treats a specific type of leukemia remains on the market, affecting tens of thousands of child patients around the world.
This segment aired on January 25, 2023.